News & Events

Neauvia wins “Best Injectable Dermal Filler” Award at AMWC 2024 Neauvia is honoured to announce its prestigious win as "Best Injectable Dermal Filler" at the AMWC 2024 Awards for its groundbreaking product, STIMULATE, the only PEG-HA + CaHA filler.

We are delighted to announce that we will be attending a number of events, shows and conferences in 2024.

We are delighted to invite you to attend our Neauvia HA-PEG Fillers Clinical Training. Discover more today...

If you are interested in learning more about the Neauvia portfolio of products, check out this handy contact sheet showing you who is your regional Sales and Business Development contact, at a glance!

We are pleased to announce LaserMe has received FDA Clearance, signifying a new key milestone for Neauvia development in the US.

AMWC 2023 congress has come to an end, this year we had the pleasure to welcome you on Neauvia's booth and treatment room.

Neauvia obtained the new CE marking under the European Union’s MDR (Medical Device Regulation) for its range of facial dermal fillers products guaranteeing clinical safety through a more stringent regulation process in comparison to its predecessor, the Medical Device Directive (MDD).

For this 22nd edition Neauvia was happy to welcome you on its booth and invite you on its scientific symposium on the safety of PEGylated HA Fillers in autoimmune patients and the synergisitic effect with infrared technology.

Neauvia was pleased to welcome you to various touch points while unveiling the new brand campaign!

At the end of 2022, Neauvia celebrated the opening of its international training center in the city of Dubai.